The elementary (K-8) school my kids attend has been struggling for several years due to staffing issues and other problems, ...

According to TMZ, a judge recently ruled on Kroy Biermann's emergency motion, granting him physical custody of their four ...

California students with undocumented parents in mixed status families are fearful of submitting FAFSA applications fearing ...

Parental Alienation (PA) is a term used to describe the refusal of a child or adolescent to engage with one parent due to the intentional or unintentional negative influence and/or manipulation of the ...

Spoiler alert! We're delving into plot details about "Lee Cronin's The Mummy" and some of its most shocking moments, so turn away now if you don't want to know what happens. Any parents who take their ...

Donald Trump is facing backlash after posting and then deleting an image depicting himself as Jesus, prompting criticism from both sides of the political spectrum. When confronted about the ...

Snap shares spiked 7% on Wednesday after billionaire CEO Evan Spiegel revealed plans to slash about 1,000 jobs and rely on artificial intelligence to take over their work. Spiegel, whose personal ...

Aaron covers what's exciting and new in the world of home entertainment and streaming TV. Previously, he wrote about entertainment for places like Rotten Tomatoes, Inverse, TheWrap and The Hollywood ...

A 14-year-old can now buy stocks on the phone without asking a parent, depending on the type of brokerage account families choose. Brokerages are rolling out accounts aimed at teens, giving parents ...

Parental control apps play a key role in improving online safety for kids by helping families manage digital exposure and monitor activity. These tools use smart filtering systems, screen time ...

Ben Hine was 4 years old when his parents split. In his recollection, he remembers that his dad left for work one day and his uncle arrived in a van to pick up Ben and his mother, along with the ...

As shares of Replimune Group (REPL) hit an all-time low on Monday of $1.50 following the US FDA's rejection of its lead asset, the melanoma drug RP1, the Street is also turning negative on the company ...